西山 博之(ニシヤマ ヒロユキ)

研究者情報全体を表示

論文
  • 精巣類表皮嚢胞の1例
    澤崎晴武; 清川岳彦; 吉田健志; 河原貴史; 井上高光; 宗田 武; 神波大己; 吉村耕治; 高橋 毅; 中村英二郎; 西山博之...
    西日本泌尿器科/68(11)/p.541-3, 2006-11
  • <症例報告>皮下腫瘤で発見されたびまん型黄色肉芽腫性腎盂腎炎の1例
    澤崎晴武; 清川岳彦; 吉田健志; 河原貴史; 井上高光; 宗田 武; 神波大己; 吉村耕治; 高橋 毅; 中村英二郎; 西山博之...
    泌尿器科紀要/52(11)/p.875-8, 2006-11
  • <症例報告>陰嚢内高分化炎症性脂肪肉腫の1例
    澤崎晴武; 中村英二郎; 星 昭夫; 西澤恒二; 吉村耕治; 高橋 毅; 清川岳彦; 西山博之; 伊藤哲之; 山本新吾; 賀本敏行...
    泌尿器科紀要/52(12)/p.961-3, 2006-12
  • 手術手技標準化による体腔鏡下手術コストの削減
    西澤恒二; 伊藤哲之; 高橋毅; 吉村耕治; 中村英二郎; 清川岳彦; 西山博之; 賀本敏行; 小川修
    Japanese Journal of Endourology and ESWL/19(2)/p.220-224, 2006-01
  • 回腸新膀胱造設術後の排尿管理指導法の現状調査
    三富陽子; 西山博之; 小川修
    日本創傷・オストミー・失禁ケア研究会誌/10(2)/p.40-43, 2006-01
  • Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species
    Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiy...
    Cancer Res./67(3)/p.1212-20, 2007-02
  • Genomic characterization of multiple clinical phenotypes of cancer using multivariate linear regression models
    Matsui S; Ito M; Nishiyama H; Uno H; Kotani H; Watanabe ...
    Bioinformatics/23(6)/p.732-8, 2007-03
  • <症例報告>術後11年目に両側上顎洞転移で再発した腎細胞癌の1例
    澤崎晴武; 清川岳彦; 吉田健志; 河原貴史; 井上高光; 宗田 武; 神波大己; 吉村耕治; 高橋 毅; 中村英二郎; 西山博之...
    泌尿器科紀要/53(4)/p.231-4, 2007-04
  • Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation
    Kawanishi H; Takahashi T; Ito M; Matsui Y; Watanabe J; It...
    Br J Cancer./97(2)/p.260-6, 2007-07
  • Solitary upper ureteral malakoplakia successfully diagnosed by ureteroscopic biopsy and treated conservatively.
    Inoue T; Nishiyama H; Yoshimura K; Ito N; Kamoto T; Habuc...
    Int J Urol./14(9)/p.859-61, 2007-09
  • P21-activated kinase 1: a new molecular marker for intravesical recurrence after transurethral resection of bladder cancer
    Ito M; Nishiyama H; Kawanishi H; Matsui S; Guilford P; Re...
    J Urol./178(3 Pt 1)/p.1073-9, 2007-09
  • Health-related quality-of-life after external beam radiation therapy for localized prostate cancer: intensity-modulated radiation therapy versus conformal radiation therapy
    Yoshimura K; Kamoto T; Nakamura E; Segawa T; Kamba T; Tak...
    Prostate Cancer Prostatic Dis./10(3)/p.288-92, 2007-09
  • Prostate specific antigen nadir determined using ultra-sensitive prostate specific antigen as a predictor of biochemical progression after radical prostatectomy in Japanese males.
    Kinoshita H; Kamoto T; Nishiyama H; Nakamura E; Matsuda ...
    Int J Urol/14(10)/p.930-4, 2007-10
  • Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney.
    Sawai K; Mukoyama M; Mori K; Kasahara M; Koshikawa M; Yok...
    Am J Physiol Renal Physiol./293(4)/p.F1363-72, 2007-10
  • Synergy of interferon-alpha and 5-fluorouracil in human renal cell carcinoma requires p53 activity.
    Shang D; Ito N; Watanabe J; Awakura Y; Nishiyama H; Kamot...
    Eur Urol./52(4)/p.1131-9, 2007-10
  • <症例報告>骨盤内に発生した弧発性線維性腫瘍の1例
    佐野剛視; 西山博之; 兼松明弘; 高橋 毅; 中村英二郎; 賀本敏行; 三上芳喜; 小山 貴; 小川 修
    泌尿器科紀要/53(12)/p.897-901, 2007-12
  • Development of a multiplex RNA urine test for the detection and stratification of transitional cell carcinoma of the bladder.
    Holyoake A; O'Sullivan P; Pollock R; Best T; Watanabe J; ...
    Clin Cancer Res./14(3)/p.742-9, 2008-02
  • Prognostic significance of HIF-1 alpha polymorphisms in transitional cell carcinoma of the bladder.
    Nadaoka J; Horikawa Y; Saito M; Kumazawa T; Inoue T; Nari...
    Int J Cancer/122(6)/p.1297-302, 2008-03
  • Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer
    Kawanishi H; Matsui Y; Ito M; Watanabe J; Takahashi T; Ni...
    Clin Cancer Res/14(9)/p.2579-87, 2008-05
  • Demethylating agent 5-aza-2'-deoxycytidine enhances susceptibility of bladder transitional cell carcinoma to Cisplatin.
    Shang D; Liu Y; Matsui Y; Ito N; Nishiyama H; Kamoto T; O...
    Urology/71(6)/p.1220-5, 2008-06
  • 尿管原発小細胞癌の1例
    増井仁彦; 神波大己; 渡部 淳; 宗田 武; 吉村耕治; 兼松明弘; 中村英二郎; 西山博之; 伊藤哲之; 賀本敏行; 小川 修
    泌尿紀要/54(6)/p.411-3, 2008-06
  • Clinical implications of the MDM2 SNP309 and p53 Arg72Pro polymorphisms in transitional cell carcinoma of the bladder
    Horikawa Y; Nadaoka J; Saito M; Kumazawa T; Inoue T; Yuas...
    Oncol Rep/20(1)/p.49-55, 2008-07
  • Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53
    Matsui Y; Watanabe J; Ikegawa M; Kamoto T; Ogawa O; Nishi...
    Oncogene/27(33)/p.4603-14, 2008-07
  • Adult wilms tumor in the renal pelvis: case report with review of the literature.
    Okasho K; Nishiyama H; Watanabe J; Soda T; Mikami Y; Koya...
    Urology/72(5)/p.1185. e5-7, 2008-11
  • Septins as diagnostic markers for a subset of human asthenozoospermia
    Sugino Y; Ichioka K; Soda T; Ihara M; Kinoshita M; Ogawa ...
    J Urol/180(6)/p.2706-9, 2008-12
  • さらに表示...